Table of Contents Author Guidelines Submit a Manuscript

Citations to this Journal [3,553 citations: 1–100 of 3,075 articles]

Articles published in Parkinson’s Disease have been cited 3,553 times. The following is a list of the 3,075 articles that have cited the articles published in Parkinson’s Disease.

  • Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Ruibing Wang, Simon Ming-Yuen Lee, and Ying Zheng, “Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity,” ACS Applied Materials & Interfaces, 2017. View at Publisher · View at Google Scholar
  • Philippe Huot, Véronique Sgambato-Faure, Susan H. Fox, and Andrew C. McCreary, “Serotonergic Approaches in Parkinson’s Disease: Translational Perspectives, an Update,” ACS Chemical Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Andrea Herrera, Patricia Muñoz, Harry W. M. Steinbusch, and Juan Segura-Aguilar, “Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson’s Disease?,” ACS Chemical Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Caixia Fan, Nuo Wang, Yannan Zhao, Hui Liang, Bin Wang, Bai Xu, Sumei Liu, Weiwei Xue, Jianwu Dai, Xing Li, Zhifeng Xiao, Sufang Han, and Xiaoran Li, “A modified collagen scaffold facilitates endogenous neurogenesis for acute spinal cord injury repair,” Acta Biomaterialia, vol. 51, pp. 304–316, 2017. View at Publisher · View at Google Scholar
  • Patrik Kutilek, Petr Volf, Rudolf Cerny, and Jan Hejda, “The application of accelerometers to measure movements of upper limbs: Pilot study,” Acta Gymnica, 2017. View at Publisher · View at Google Scholar
  • Francesco Longo, Daniela Mercatelli, Salvatore Novello, Ludovico Arcuri, Alberto Brugnoli, Fabrizio Vincenzi, Isabella Russo, Giulia Berti, Omar S. Mabrouk, Robert T. Kennedy, Derya R. Shimshek, Katia Varani, Luigi Bubacco, Elisa Greggio, and Michele Morari, “Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice,” Acta Neuropathologica Communications, vol. 5, no. 1, 2017. View at Publisher · View at Google Scholar
  • Maria Nord, Peter Zsigmond, Anita Kullman, and Nil Dizdar, “Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease,” Advances in Parkinson's Disease, vol. 06, no. 02, pp. 52–66, 2017. View at Publisher · View at Google Scholar
  • Pamela Latino, Stefania Tagliente, Clelia Pellicano, Morena Giovannelli, and Francesco E. Pontieri, “Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions,” Advances in Parkinson's Disease, vol. 06, no. 01, pp. 13–23, 2017. View at Publisher · View at Google Scholar
  • Christoph U. Correll, Nicola Veronese, Trevor Thompson, Katy Gallop, Andre F. Carvalho, Ellen Wright, and Brendon Stubbs, “Pain perception in Parkinson's disease: A systematic review and meta-analysis of experimental studies,” Ageing Research Reviews, vol. 35, pp. 74–86, 2017. View at Publisher · View at Google Scholar
  • Frederic Gilbert, Eliza Goddard, John Noel M. Viaña, Adrian Carter, and Malcolm Horne, “I Miss Being Me: Phenomenological Effects of Deep Brain Stimulation,” AJOB Neuroscience, vol. 8, no. 2, pp. 96–109, 2017. View at Publisher · View at Google Scholar
  • Tobias Luck, Francisca S. Then, Matthias L. Schroeter, Markus Loeffler, Joachim Thiery, Steffi G. Riedel-Heller, Veronica Witte, Christoph Engel, and Arno Villringer, “Prevalence of DSM-5 Mild Neurocognitive Disorder in Dementia-Free Older Adults: Results of the Population-Based LIFE-Adult-Study,” American Journal of Geriatric Psychiatry, vol. 25, no. 4, pp. 328–339, 2017. View at Publisher · View at Google Scholar
  • Eva Pirogovsky-Turk, Stephanie L. Lessig, Dawn M. Schiehser, Raeanne C. Moore, J. Vincent Filoteo, Irene Litvan, and David D. Song, “Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study,” American Journal of Geriatric Psychiatry, vol. 25, no. 3, pp. 279–289, 2017. View at Publisher · View at Google Scholar
  • Byron Creese, Emily Bell, Iskandar Johar, Paul Francis, Clive Ballard, and Dag Aarsland, “Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2017. View at Publisher · View at Google Scholar
  • Rachel A. Davis, Christopher S. Sharp, Steven Ojemann, Alison M. Heru, Christen H. Epstein, Olga Klepitskaya, and Aviva Abosch, “Disambiguating the psychiatric sequelae of Parkinson's disease, deep brain stimulation, and life events: Case report and literature review,” American Journal of Psychiatry, vol. 174, no. 1, pp. 11–15, 2017. View at Publisher · View at Google Scholar
  • Kristen M. Allison, Yana Yunusova, Thomas F. Campbell, Jun Wang, James D. Berry, and Jordan R. Green, “The diagnostic utility of patient-report and speech-language pathologists’ ratings for detecting the early onset of bulbar symptoms due to ALS,” Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Silke Appel-Cresswell, Helen Tremlett, Kylynda C. Bauer, Brett B. Finlay, and Emmanuelle Waubant, “The gut microbiome in human neurological disease: A review,” Annals of Neurology, vol. 81, no. 3, pp. 369–382, 2017. View at Publisher · View at Google Scholar
  • Ju Gao, Luwen Wang, Jingyi Liu, Fei Xie, Bo Su, and Xinglong Wang, “Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases,” Antioxidants, vol. 6, no. 2, pp. 25, 2017. View at Publisher · View at Google Scholar
  • Justin W.L. Keogh, Tim Henwood, Anthony Tuckett, Brent Hodgkinson, Kevin Rouse, and Paul Gardiner, “Examining evidence based resistance plus balance training in community-dwelling older adults with complex health care needs: Trial protocol for the Muscling Up Against Disability project,” Archives of Gerontology and Geriatrics, vol. 68, pp. 97–105, 2017. View at Publisher · View at Google Scholar
  • Chiahao Lu, Sommer L. Amundsen Huffmaster, Paul J. Tuite, Jacqueline M. Vachon, and Colum D. MacKinnon, “Effect of Cue Timing and Modality on Gait Initiation in Parkinson Disease With Freezing of Gait,” Archives of Physical Medicine and Rehabilitation, 2017. View at Publisher · View at Google Scholar
  • Maria João Valente, Cristina Amaral, Georgina Correia-da-Silva, José Alberto Duarte, Maria de Lourdes Bastos, Félix Carvalho, Paula Guedes de Pinho, and Márcia Carvalho, “Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity,” Archives of Toxicology, 2017. View at Publisher · View at Google Scholar
  • Kimberley A. Phillips, Jennifer Spross, Catherine J. Cheng, Biju, Corinna N. Ross, Alyssa Izquierdo, Cang Chen, Senlin Li, and Suzette D. Tardif, “Behavioral phenotypes associated with MPTP induction of partial lesions in common marmosets (Callithrix jacchus),” Behavioural Brain Research, vol. 325, pp. 51–62, 2017. View at Publisher · View at Google Scholar
  • Willie M.U. Daniels, Musa V. Mabandla, and Ernest Dallé, “Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression,” Behavioural Brain Research, vol. 316, pp. 189–196, 2017. View at Publisher · View at Google Scholar
  • Zhipai Lyu, Jiyu Lou, Qian Bai, Zhenjie Pan, and Tieli Dong, “Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke,” Behavioural Brain Research, vol. 321, pp. 79–86, 2017. View at Publisher · View at Google Scholar
  • Andrew Vo, Ken N. Seergobin, and Penny A. MacDonald, “Effects of levodopa on stimulus-response learning versus response selection in healthy young adults,” Behavioural Brain Research, vol. 317, pp. 553–561, 2017. View at Publisher · View at Google Scholar
  • Cédrick T. Bonnet, Arnaud Delval, Sébastien Szaffarczyk, and Luc Defebvre, “Levodopa has primarily negative influences on postural control in patients with Parkinson's disease,” Behavioural Brain Research, 2017. View at Publisher · View at Google Scholar
  • Alexandra I. Rosa, Inês Fonseca, Maria João Nunes, Sara Moreira, Elsa Rodrigues, Andreia Neves Carvalho, Cecília M.P. Rodrigues, Maria João Gama, and Margarida Castro-Caldas, “Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  • S. Barata-Antunes, A.C. Cristóvão, J. Pires, M.S. Rocha, and L. Bernardino, “Dual role of histamine on microglia-induced neurodegeneration,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  • Toshiaki Kume, “Therapeutic Potential of the Activators of the Nuclear Factor Erythroid 2-Related Factor 2–Antioxidant Response Element Pathway in Brain Disorders,” Biological and Pharmaceutical Bulletin, vol. 40, no. 5, pp. 553–556, 2017. View at Publisher · View at Google Scholar
  • Juan M. Zolezzi, Manuel J. Santos, Sussy Bastías-Candia, Claudio Pinto, Juan A. Godoy, and Nibaldo C. Inestrosa, “PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation,” Biological Reviews, 2017. View at Publisher · View at Google Scholar
  • Naomi P. Visanji, Danna Jennings, Brit Mollenhauer, Thomas G. Beach, Christopher S. Coffey, Catherine M. Kopil, Kuldip D. Dave, Tatiana Foroud, Charles H. Adler, and Lana Chahine, “The Systemic Synuclein Sampling Study: Toward a biomarker for Parkinson's disease,” Biomarkers in Medicine, vol. 11, no. 4, pp. 359–368, 2017. View at Publisher · View at Google Scholar
  • Serena A. Allen, Stephanie Rednour, Samantha Shepard, and Brooks Barnes Pond, “A simple and sensitive high-performance liquid chromatography-electrochemical detection assay for the quantitative determination of monoamines and respective metabolites in six discrete brain regions of mice,” Biomedical Chromatography, pp. e3998, 2017. View at Publisher · View at Google Scholar
  • Tourandokht Baluchnejadmojarad, Monireh Mansouri, Jamileh Ghalami, Zahra Mokhtari, and Mehrdad Roghani, “Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress,” Biomedicine & Pharmacotherapy, vol. 88, pp. 754–761, 2017. View at Publisher · View at Google Scholar
  • Siamak Afshin-Majd, Keyhan Bashiri, Zahra Kiasalari, Tourandokht Baluchnejadmojarad, Reza Sedaghat, and Mehrdad Roghani, “Acetyl- l -carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson’s disease in the rat,” Biomedicine & Pharmacotherapy, vol. 89, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Komal Panchal, and Anand K. Tiwari, “Drosophila melanogaster “a potential model organism” for identification of pharmacological properties of plants/plant-derived components,” Biomedicine & Pharmacotherapy, vol. 89, pp. 1331–1345, 2017. View at Publisher · View at Google Scholar
  • Debayan Goswami, Rashmi Das, Nidhi S. Chandra, Tapan K. Chatterjee, Amit Chakravarty, Sudipa Chakravarty, Anwesha Bhowmik, Durbadal Ojha, and Debprasad Chattopadhyay, “Inositol hexa phosphoric acid (phytic acid), a nutraceuticals, attenuates iron-induced oxidative stress and alleviates liver injury in iron overloaded mice,” Biomedicine and Pharmacotherapy, vol. 87, pp. 443–450, 2017. View at Publisher · View at Google Scholar
  • Håkan Nero, Maria Hagströmer, David Conradsson, Niklas Löfgren, and Erika Franzén, “Monitoring training activity during gait-related balance exercise in individuals with Parkinson's disease: A proof-of-concept-study,” BMC Neurology, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Erin Oerton, and Andreas Bender, “Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies,” BMC Neurology, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Zahra Yarjanli, Kamran Ghaedi, Abolghasem Esmaeili, Soheila Rahgozar, and Ali Zarrabi, “Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation,” BMC Neuroscience, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Dae-In Chang, Danny Mollerup Sørensen, Bob Asselbergh, Christine Klein, Stephan Zuchner, Albena Jordanova, Peter Vangheluwe, Rebecca Schüle, Matthis Synofzik, Dagmar Timmann, Albena Andreeva, Jennifer Reichbauer, Riet De Rycke, Alejandro Estrada-Cuzcano, Sarah Van Veen, Jean Samuel, Ludger Schöls, Thorsten Pöppel, Shaun Martin, Ivailo Tournev, Teodora Chamova, and Tine Holemans, “Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78),” Brain, vol. 140, no. 2, pp. 287–305, 2017. View at Publisher · View at Google Scholar
  • Audrey A. Hazamy, Lori J.P. Altmann, Elizabeth Stegemöller, Dawn Bowers, Hyo Keun Lee, Jonathan Wilson, Michael S. Okun, and Chris J. Hass, “Improved cognition while cycling in Parkinson’s disease patients and healthy adults,” Brain and Cognition, vol. 113, pp. 23–31, 2017. View at Publisher · View at Google Scholar
  • Krisztina Szalisznyó, David Silverstein, Marc Teichmann, Anja Smits, and Hugues Duffau, “Cortico-striatal language pathways dynamically adjust for syntactic complexity: A computational study,” Brain and Language, vol. 164, pp. 53–62, 2017. View at Publisher · View at Google Scholar
  • Marlene Jimenez-Del-Rio, Carlos Velez-Pardo, and Diana Quintero-Espinosa, “Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease,” Brain Research, vol. 1657, pp. 253–261, 2017. View at Publisher · View at Google Scholar
  • Fabienne Ory-Magne, Monique Galitzky, Christine Brefel-Courbon, Simona Celebrini, Alexandra Séverac Cauquil, Vincent Jardiné, and Maxime Rosito, “Parkinson's patients can rely on perspective cues to perceive 3D space,” Brain Research, vol. 1663, pp. 161–165, 2017. View at Publisher · View at Google Scholar
  • Juciano Gasparotto, Camila Tiefensee Ribeiro, Rafael Calixto Bortolin, Nauana Somensi, Henrique Schaan Fernandes, Alexsander Alves Teixeira, Marcelo Otavio Rodrigues Guasselli, Crepin Aziz Jose O. Agani, Natália Cabral Souza, Mateus Grings, Guilhian Leipnitz, Henrique Mautone Gomes, Matheus Augusto de Bittencourt Pasquali, Peter R. Dunkley, Phillip W. Dickson, José Claudio Fonseca Moreira, and Daniel Pens Gelain, “Anti-RAGE antibody selectively blocks acute systemic inflammatory responses to LPS in serum, liver, CSF and striatum,” Brain, Behavior, and Immunity, 2017. View at Publisher · View at Google Scholar
  • Amit Khairnar, Irena Rektorova, Jana Ruda-Kucerova, Anas Arab, Birgit Hutter-Paier, Joerg Neddens, Peter Latta, Zenon Starcuk, Nikoletta Szabó, and Eva Drazanova, “Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging,” Brain, Behavior, and Immunity, vol. 61, pp. 197–208, 2017. View at Publisher · View at Google Scholar
  • Christopher J Lovegrove, Katrina Bannigan, Debbie Cheeseman, and Jos M Latour, “The involvement of people with Parkinson’s in designing a study of the lived experience of anxiety,” British Journal of Occupational Therapy, pp. 030802261770065, 2017. View at Publisher · View at Google Scholar
  • Angie M. Ameen, Amany Y. Elkazaz, Hala M.F. Mohammad, and Bassant M. Barakat, “Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats,” Canadian Journal of Physiology and Pharmacology, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Marta Delgado-Camprubi, Noemi Esteras, Marc Pm Soutar, Helene Plun-Favreau, and Andrey Y. Abramov, “Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation,” Cell Death and Differentiation, vol. 24, no. 1, pp. 120–131, 2017. View at Publisher · View at Google Scholar
  • Stefano Gustincich, Maria Bertuzzi, Roberta Russo, Stefano Espinoza, Lorena Zentilin, Antonio Paolo Beltrami, Marta Codrich, Paolo Ascenzi, Silvia Zucchelli, Francesca Persichetti, Giampiero Leanza, Margherita Francescatto, Mauro Giacca, and Daniela Cesselli, “Neuronal hemoglobin affects dopaminergic cells' response to stress,” Cell Death and Disease, vol. 8, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yan Shen, Xingfang Guo, Chao Han, Fang Wan, Kai Ma, Shiyi Guo, Luxi Wang, Yun Xia, Ling Liu, Zhicheng Lin, Jinsha Huang, Nian Xiong, and Tao Wang, “The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson?s disease,” Cellular and Molecular Life Sciences, 2017. View at Publisher · View at Google Scholar
  • Nora Slekiene, Lina Ramanauskaite, and Valentinas Snitka, “Surface enhanced Raman spectroscopy of self-assembled layers of lipid molecules on nanostructured Au and Ag substrates,” Chemistry and Physics of Lipids, 2017. View at Publisher · View at Google Scholar
  • Li-Jing Ma, Yun-Ting Fu, Cheng-Jie Mao, Fei Han, Yun Shen, Yi Wang, Jie Li, and Chun-Feng Liu, “Study on the correlation between two common sleep disorders in Parkinson's disease,” Chinese Journal of Contemporary Neurology and Neurosurgery, vol. 17, no. 1, pp. 31–38, 2017. View at Publisher · View at Google Scholar
  • Piu Chan, and Shan-Shan Mei, “The most pressing issue of standardizing the preoperative assessment of deep brain stimulation,” Chinese Journal of Contemporary Neurology and Neurosurgery, vol. 17, no. 2, pp. 85–87, 2017. View at Publisher · View at Google Scholar
  • Dieter Willbold, Christian Zafiu, Luriano Peters, Oliver Bannach, Yvonne Herrmann, Dieter Willbold, Andreas Kulawik, Katja Kühbach, Judith Fabig, and Johannes Willbold, “Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies,” Clinica Chimica Acta, vol. 466, pp. 152–159, 2017. View at Publisher · View at Google Scholar
  • Michael Kukulka, Sai Nudurupati, and Maria Claudia Perez, “Bioavailability of a dexlansoprazole Delayed-Release orally disintegrating tablet: Effects of food and mode of administration,” Clinical and Experimental Gastroenterology, vol. 10, pp. 47–56, 2017. View at Publisher · View at Google Scholar
  • Jianfeng Li, Jun-Ping Liu, Yanhua Lu, Lihui Wang, and Gang Chen, “Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism,” Clinical and Experimental Pharmacology and Physiology, vol. 44, no. 2, pp. 172–179, 2017. View at Publisher · View at Google Scholar
  • Thekkuttuparambil Ananthanarayanan Ajith, Ben Sundra Ashok, and Senthilkumar Sivanesan, “Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease,” Clinical and Experimental Pharmacology and Physiology, vol. 44, no. 3, pp. 327–334, 2017. View at Publisher · View at Google Scholar
  • Shalabh Srivastava, Akhilesh Kumar Verma, Janak Raj, Vivek Sharma, Tej Bali Singh, and Ragini Srivastava, “Epidemiology and associated risk factors of Parkinson's disease among the north Indian population,” Clinical Epidemiology and Global Health, vol. 5, no. 1, pp. 8–13, 2017. View at Publisher · View at Google Scholar
  • Shashank Ghai, Ishan Ghai, and Alfred O. Effenberg, “Effects of dual tasks and dual-task training on postural stability: A systematic review and meta-analysis,” Clinical Interventions in Aging, vol. 12, pp. 557–577, 2017. View at Publisher · View at Google Scholar
  • Radu Constantinescu, Barbro Eriksson, Yvonne Jansson, Bo Johnels, Björn Holmberg, Thordis Gudmundsdottir, Annika Renck, Peter Berglund, and Filip Bergquist, “Key clinical milestones 15 years and onwards after DBS-STN surgery − a retrospective analysis of patients that underwent surgery between 1993 and 2001,” Clinical Neurology and Neurosurgery, 2017. View at Publisher · View at Google Scholar
  • Richard B. Reilly, Timothy Lynch, John S. Butler, Conor Fearon, Isabelle Killane, and Saskia M. Waechter, “Motor preparation rather than decision-making differentiates Parkinson's disease patients with and without freezing of gait,” Clinical Neurophysiology, vol. 128, no. 3, pp. 463–471, 2017. View at Publisher · View at Google Scholar
  • Carding, Bos-Clark, Walton, Fu, Gillivan-Murphy, and Jones, “Evaluating the efficacy of voice therapy for functional, organic and neurological voice disorders,” Clinical Otolaryngology, vol. 42, no. 2, pp. 201–217, 2017. View at Publisher · View at Google Scholar
  • Leyre Riancho-Zarrabeitia, and Manuel Delgado-Alvarado, “Bone Health in Parkinson?s Disease,” Clinical Reviews in Bone and Mineral Metabolism, 2017. View at Publisher · View at Google Scholar
  • Aleksandra Gruszka, Adam Hampshire, Roger A. Barker, and Adrian M. Owen, “Normal aging and Parkinson’s Disease are associated with the functional decline of distinct frontal-striatal circuits,” Cortex, 2017. View at Publisher · View at Google Scholar
  • Kaie Rosborough, Neha Patel, and Lorraine V. Kalia, “α-Synuclein and Parkinsonism: Updates and Future Perspectives,” Current Neurology and Neuroscience Reports, vol. 17, no. 4, 2017. View at Publisher · View at Google Scholar
  • Seyed-Mohammad Fereshtehnejad, and Ronald B. Postuma, “Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?,” Current Neurology and Neuroscience Reports, vol. 17, no. 4, 2017. View at Publisher · View at Google Scholar
  • Miguel Cuina Lopez, Pierre-Olivier Fernagut, Wassilios G. Meissner, Brice Laurens, Sylvain Vergnet, Alexandra Foubert-Samier, and François Tison, “Multiple System Atrophy - State of the Art,” Current Neurology and Neuroscience Reports, vol. 17, no. 5, 2017. View at Publisher · View at Google Scholar
  • Sandra Tenreiro, Vanessa Franssens, Joris Winderickx, and Tiago Fleming Outeiro, “Yeast models of Parkinson's disease-associated molecular pathologies,” Current Opinion in Genetics and Development, vol. 44, pp. 74–83, 2017. View at Publisher · View at Google Scholar
  • Robert Lütjens, and Jean-Philippe Rocher, “Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders,” Current Opinion in Pharmacology, vol. 32, pp. 91–95, 2017. View at Publisher · View at Google Scholar
  • Giulia Elisabetta Lombardi, Andrea Galbiati, Luigi Ferini-Strambi, and Sara Marelli, “Neurological Deficits in Obstructive Sleep Apnea,” Current Treatment Options in Neurology, vol. 19, no. 4, 2017. View at Publisher · View at Google Scholar
  • K. Brockmann, and K. Lohmann, “Genetische Risikovarianten beim Parkinson-Syndrom und anderen Bewegungsstörungen,” Der Nervenarzt, 2017. View at Publisher · View at Google Scholar
  • W. H. Jost, “Nichtmotorische Symptome beim Morbus Parkinson,” Der Nervenarzt, 2017. View at Publisher · View at Google Scholar
  • Heather Hunter, Lynn Rochester, Rosie Morris, and Sue Lord, “Longitudinal falls data in Parkinson’s disease: feasibility of fall diaries and effect of attrition,” Disability and Rehabilitation, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Aleksandra Kudlicka, John V. Hindle, Laura E. Spencer, and Linda Clare, “Everyday functioning of people with Parkinson?s disease and impairments in executive function: a qualitative investigation,” Disability and Rehabilitation, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Kathryn G. Wallin-Miller, Jordyn Chesley, Juliana Castrillon, and Ruth I. Wood, “Sex differences and hormonal modulation of ethanol-enhanced risk taking in rats,” Drug and Alcohol Dependence, vol. 174, pp. 137–144, 2017. View at Publisher · View at Google Scholar
  • Gargi Ganguly, Luciano Saso, Sasanka Chakrabarti, and Uttara Chatterjee, “Proteinopathy, oxidative stress and mitochondrial dysfunction: Cross talk in alzheimer’s disease and parkinson’s disease,” Drug Design, Development and Therapy, vol. 11, pp. 797–810, 2017. View at Publisher · View at Google Scholar
  • Sofiane Kab, Johan Spinosi, Laura Chaperon, Aline Dugravot, Archana Singh-Manoux, Frédéric Moisan, and Alexis Elbaz, “Agricultural activities and the incidence of Parkinson’s disease in the general French population,” European Journal of Epidemiology, vol. 32, no. 3, pp. 203–216, 2017. View at Publisher · View at Google Scholar
  • Austin Quach, Devin Absher, Yu-Hsuan Chuang, Themistocles Assimes, Steve Horvath, and Beate Ritz, “Coffee consumption is associated with DNA methylation levels of human blood,” European Journal of Human Genetics, vol. 25, no. 5, pp. 608–616, 2017. View at Publisher · View at Google Scholar
  • Canning, Boufous, Sherrington, Paul, Harvey, Lord, and Close, “Fall-related hospitalization in people with Parkinson's disease,” European Journal of Neurology, vol. 24, no. 3, pp. 523–529, 2017. View at Publisher · View at Google Scholar
  • Samuel Stuart, Brook Galna, Louise S. Delicato, Sue Lord, and Lynn Rochester, “Direct and indirect effects of attention and visual function on gait impairment in Parkinson's disease: influence of task and turning,” European Journal of Neuroscience, 2017. View at Publisher · View at Google Scholar
  • Julianna J. Tomlinson, Goncalo Santos, Tiago Mestre, Michael G. Schlossmacher, Bojan Shutinoski, Earl G. Brown, and Douglas Manuel, “Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score,” European Journal of Neuroscience, vol. 45, no. 1, pp. 175–191, 2017. View at Publisher · View at Google Scholar
  • Kelly M. Lohr, Shababa T. Masoud, Ali Salahpour, and Gary W. Miller, “Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease,” European Journal of Neuroscience, vol. 45, no. 1, pp. 20–33, 2017. View at Publisher · View at Google Scholar
  • Katarzyna Regulska, Anna Wzgarda, Robert Kleszcz, Monika Prokop, Milosz Regulski, Jaroslaw Paluszczak, and Beata J. Stanisz, “Unknown face of known drugs – what else can we expect from angiotensin converting enzyme inhibitors?,” European Journal of Pharmacology, vol. 797, pp. 9–19, 2017. View at Publisher · View at Google Scholar
  • Antonia Pierobon, Marina Maffoni, Anna Giardini, Simona Callegari, Gabriella Bertotti, Davide Ferrazzoli, and Giuseppe Frazzitta, “Towards proactive active living: Patients with Parkinson's disease experience of a multidisciplinary intensive rehabilitation treatment,” European Journal of Physical and Rehabilitation Medicine, vol. 53, no. 1, pp. 114–124, 2017. View at Publisher · View at Google Scholar
  • Annamária Juhász, Gabriella Deli, Zsuzsanna Aschermann, József Janszky, Márk Harmat, Attila Makkos, Márton Kovács, Sámuel Komoly, István Balás, Tamás Dóczi, András Büki, and Norbert Kovács, “How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson's Disease?,” European Neurology, pp. 281–287, 2017. View at Publisher · View at Google Scholar
  • Alexandre Batista Penido, Selene Maia De Morais, Alan Bezerra Ribeiro, Daniela Ribeiro Alves, Ana Livya Moreira Rodrigues, Leonardo Hunaldo dos Santos, and Jane Eire Silva Alencar de Menezes, “Medicinal Plants from Northeastern Brazil against Alzheimer’s Disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Chuanhe Sun, Dandan Wang, Wenfei Jiang, Weilong Liao, Penglin Gao, Weidong Pan, and Te Liu, “Quantitative Evaluation of Chinese Herb Medicine in the Treatment of Sialorrhea and Frequent Nighttime Urination in Patients with Parkinson’s Disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Nabil El Massri, Ana P. Lemgruber, Isobel J. Rowe, Cécile Moro, Napoleon Torres, Florian Reinhart, Claude Chabrol, Alim-Louis Benabid, and John Mitrofanis, “Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum,” Experimental Brain Research, 2017. View at Publisher · View at Google Scholar
  • Qiong Cai, Ming Jiang, Jia Guo, Hui Sun, Jianmin Fang, Lingjing Jin, Jingxing Zhang, Yigang Liu, and Hua Gu, “Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition,” Experimental Gerontology, vol. 89, pp. 45–56, 2017. View at Publisher · View at Google Scholar
  • Hongpeng Guan, Ikuo Tooyama, Hongkuan Yang, Mingchun Yang, Masaki Mori, Shiguang Zhao, Daijiro Yanagisawa, Jean-Pierre Bellier, Shogo Takahata, and Takashi Nonaka, “Mitochondrial ferritin protects SH-SY5Y cells against H2O2-induced oxidative stress and modulates α-synuclein expression,” Experimental Neurology, vol. 291, pp. 51–61, 2017. View at Publisher · View at Google Scholar
  • Petra Fischer, Alek Pogosyan, Binith Cheeran, Alexander L. Green, Tipu Z. Aziz, Jonathan Hyam, Simon Little, Thomas Foltynie, Patricia Limousin, Ludvic Zrinzo, Marwan Hariz, Michael Samuel, Keyoumars Ashkan, Peter Brown, and Huiling Tan, “Subthalamic nucleus beta and gamma activity is modulated depending on the level of imagined grip force,” Experimental Neurology, 2017. View at Publisher · View at Google Scholar
  • Jan Lewerenz, Joeri Van Liefferinge, Katleen Martens, Sho Kobayashi, Lauren Deneyer, Katrien Maes, Eduard Bentea, Hideyo Sato, Ilse Smolders, Ann Massie, Lise Verbruggen, Thomas Demuyser, and Giulia Albertini, “Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc−,” Experimental Neurology, vol. 290, pp. 15–28, 2017. View at Publisher · View at Google Scholar
  • Carvalho, Carvalho, Moura, Arcanjo, Citó, Sobrinho-Junior, Brito, Nicolau, Carvalho, Rodrigues, and Carneiro, “Anti-Leishmania activity of essential oil of Myracrodruon urundeuva (Engl.) Fr. All.: Composition, cytotoxity and possible mechanisms of action,” Experimental Parasitology, vol. 175, pp. 59–67, 2017. View at Publisher · View at Google Scholar
  • Sumit Ghosh, Priyanka Basak, Sayanta Dutta, Sayantani Chowdhury, and Parames C. Sil, “New insights into the ameliorative effects of ferulic acid in pathophysiological conditions,” Food and Chemical Toxicology, vol. 103, pp. 41–55, 2017. View at Publisher · View at Google Scholar
  • Francisco José Sanz, Cristina Solana-Manrique, Verónica Muñoz-Soriano, Pablo Calap-Quintana, María Dolores Moltó, and Nuria Paricio, “Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models,” Free Radical Biology and Medicine, 2017. View at Publisher · View at Google Scholar
  • Anderson H. F. F. Leão, Ywlliane S. R. Meurer, Anatildes F. da Silva, André M. Medeiros, Clarissa L. C. Campêlo, Vanessa C. Abílio, Rovena C. G. K. Engelberth, Jeferson S. Cavalcante, Geison S. Izídio, Alessandra M. Ribeiro, and Regina H. Silva, “Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson’s Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression,” Frontiers in Aging Neuroscience, vol. 9, 2017. View at Publisher · View at Google Scholar
  • Joseph M. Thomas, Tianxia Li, Wei Yang, Fengtian Xue, Paul S. Fishman, and Wanli W. Smith, “68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment,” Frontiers in Aging Neuroscience, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Hui Li, Xiuqin Jia, Zhigang Qi, Xiang Fan, Tian Ma, Hong Ni, Chiang-shan R. Li, and Kuncheng Li, “Altered Functional Connectivity of the Basal Nucleus of Meynert in Mild Cognitive Impairment: A Resting-State fMRI Study,” Frontiers in Aging Neuroscience, vol. 9, 2017. View at Publisher · View at Google Scholar
  • Deborah L. Harrington, Qian Shen, Gabriel N. Castillo, J. Vincent Filoteo, Irene Litvan, Colleen Takahashi, and Chelsea French, “Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson’s Disease,” Frontiers in Aging Neuroscience, vol. 9, 2017. View at Publisher · View at Google Scholar
  • Davide Ferrazzoli, Paola Ortelli, Roberto Maestri, Rossana Bera, Roberto Gargantini, Grazia Palamara, Marianna Zarucchi, Nir Giladi, and Giuseppe Frazzitta, “Focused and Sustained Attention Is Modified by a Goal-Based Rehabilitation in Parkinsonian Patients,” Frontiers in Behavioral Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar